相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
Sourav Das et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Structural insights of metallo-beta-lactamase revealed an effective way of inhibition of enzyme by natural inhibitors
Bhavya Somalapura Gangadharappa et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
BAX, BAK, and BOK: A Coming of Age for the BCL-2 Family Effector Proteins
Tudor Moldoveanu et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2020)
The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms
Suresh Banjara et al.
BIOMOLECULES (2020)
Noncanonical Cell Fate Regulation by Bcl-2 Proteins
Stephen Jun Fei Chong et al.
TRENDS IN CELL BIOLOGY (2020)
Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (M-pro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation
Priyashi Rao et al.
BIOPHYSICAL CHEMISTRY (2020)
Structure based pharmacophore modelling approach for the design of azaindole derivatives as DprE1 inhibitors for tuberculosis
K. B. Suma et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2020)
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations
Richard W. Birkinshaw et al.
NATURE COMMUNICATIONS (2019)
Current overview on the clinical update of Bcl-2 anti-apoptotic inhibitors for cancer therapy
Vasanti Suvarna et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Targeting BCL-2 regulated apoptosis in cancer
Kirsteen J. Campbell et al.
OPEN BIOLOGY (2018)
Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy
Marilina Garcia-Aranda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Anti-apoptotic BCL-2 family members in development
Joseph T. Opferman et al.
CELL DEATH AND DIFFERENTIATION (2018)
BCL-2 family proteins: changing partners in the dance towards death
Justin Kale et al.
CELL DEATH AND DIFFERENTIATION (2018)
The BCL-2 arbiters of apoptosis and their growing role as cancer targets
Jerry M. Adams et al.
CELL DEATH AND DIFFERENTIATION (2018)
Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations
Kai Liu et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2017)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Samuel Genheden et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
BH3-only proteins in apoptosis at a glance
Lina Happo et al.
JOURNAL OF CELL SCIENCE (2012)
Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
Matthew S. Davids et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
Wyndham H. Wilson et al.
LANCET ONCOLOGY (2010)
Structural biology of the Bcl-2 family of proteins
AM Petros et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Oblimersen bcl-2 antisense: Facilitating apoptosis in anticancer treatment
RJ Klasa et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2002)
Apoptosis-based therapies
JC Reed
NATURE REVIEWS DRUG DISCOVERY (2002)
分享论文
